{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:39:08Z","timestamp":1783456748925,"version":"3.55.0"},"reference-count":41,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy &amp; Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy\/nursing in-services. A comprehensive target drug utilization evaluation\/medication use evaluation (DUE\/MUE) is also provided each month. With a subscription, the monographs are are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433. The November 2016 monograph topics are apaziquone, crisaborole, irinotecan liposome, plecanatide, and telotristat. The Safety MUE is on methylnaltrexone PO.<\/jats:p>","DOI":"10.1310\/hpj5110-847","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T13:24:02Z","timestamp":1480685042000},"page":"847-854","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":23,"title":["Defibrotide"],"prefix":"10.1177","volume":"51","author":[{"given":"Danial E.","family":"Baker","sequence":"first","affiliation":[{"name":"Drug Information Center, and College of Pharmacy, Washington State University Spokane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Demaris","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Washington State University Spokane"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"bibr1-hpj5110-847","volume-title":"Defitelio (defibrotide sodium) [prescribing information].","year":"2016"},{"key":"bibr2-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.08.024"},{"key":"bibr3-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60067-1"},{"key":"bibr4-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2012.01604.x"},{"key":"bibr5-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215591387"},{"key":"bibr6-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.10.002"},{"key":"bibr7-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2010.01311.x"},{"key":"bibr8-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.02.009"},{"key":"bibr9-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12859"},{"key":"bibr10-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.240291"},{"key":"bibr11-hpj5110-847","unstructured":"Defibrotide. ClinicalTrials.gov website. https:\/\/clinicaltrials.gov\/ct2\/results?term=defibrotide+&Search=Search. Accessed May 7, 2016."},{"key":"bibr12-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017913"},{"key":"bibr13-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61938-7"},{"key":"bibr14-hpj5110-847","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00431-009-1136-4","volume":"169","author":"Corbacioglu S.","year":"2010","journal-title":"Eur J Pediatr."},{"key":"bibr15-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2004.01.002"},{"key":"bibr16-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705485"},{"key":"bibr17-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705696"},{"key":"bibr18-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21425"},{"issue":"6","key":"bibr19-hpj5110-847","first-page":"795","volume":"91","author":"Haussmann U.","year":"2006","journal-title":"Heamatologica."},{"key":"bibr20-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-001-0316-z"},{"key":"bibr21-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.01.009"},{"key":"bibr22-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199345020-00007"},{"key":"bibr23-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149682"},{"issue":"1","key":"bibr24-hpj5110-847","first-page":"26","volume":"16","author":"Noseda G.","year":"1986","journal-title":"Haemostasis."},{"key":"bibr25-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15427.x"},{"key":"bibr26-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.11.019"},{"key":"bibr27-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90864-E"},{"key":"bibr28-hpj5110-847","first-page":"64","volume":"14","author":"Cornelli U.","year":"1988","journal-title":"Semin Thromb Hemost."},{"key":"bibr29-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12558"},{"issue":"4","key":"bibr30-hpj5110-847","first-page":"1122","volume":"111","author":"Chopra R.","year":"2000","journal-title":"Br J Haematol."},{"key":"bibr31-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704329"},{"key":"bibr32-hpj5110-847","author":"Richardson P.","year":"2009","journal-title":"Defibrotide (DF) in the Treatment of severe hepatic veno-occlusive disease (VOD) with multi-organ failure (MOF) following stem cell transplantation (SCT): Results of a phase 3 study utilizing a historical control [abstract]."},{"key":"bibr33-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-676924"},{"key":"bibr34-hpj5110-847","author":"Richardson P.G.","year":"2011","journal-title":"Defibrotide (DF) in the treatment of hepatic veno-occlusive disease (VOD) in stem cell transplant (SCT) and non-SCT patients (pts): Early intervention improves outcome-updated results of a treatment and expanded access protocol [abstract]."},{"key":"bibr35-hpj5110-847","unstructured":"Jazz Pharmaceuticals. Defibrotide for patients with hepatic veno-occlusive disease: A treatment IND study (treatment IND). ClinicalTrials.gov website. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00628498. Updated April 11, 2016. Accessed May 2016. NLM Identifier: NCT00628498."},{"key":"bibr36-hpj5110-847","unstructured":"PazdurR. NDA approval letter: Defitelio (defibrotide sodium NDA 208114). US Food and Drug Administration website. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2016\/208114Orig1s000ltr.pdf. Published March 30, 2016. Accessed April 12, 2016."},{"key":"bibr37-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.11.135"},{"key":"bibr38-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.08.013"},{"key":"bibr39-hpj5110-847","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130700"},{"key":"bibr40-hpj5110-847","unstructured":"Gentium announces NDA submission for defibrotide [press release]. Villa Guardia (Como), Italy: Gentium S.p.A; July 6, 2011. https:\/\/globenewswire.com\/news-release\/2011\/07\/06\/450667\/225848\/en\/Gentium-Announces-NDA-Submission-for-Defibrotide.html. Accessed April 27, 2012."},{"key":"bibr41-hpj5110-847","unstructured":"Gentium withdraws new drug application for defibrotide [press release]. Villa Guardia (Como), Italy: Gentium S.p.A; August 17, 2011. https:\/\/globenewswire.com\/news-release\/2011\/08\/17\/454207\/229854\/en\/Gentium-Withdraws-New-Drug-Application-for-Defibrotide.html. Accessed June 4, 2012."}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1310\/hpj5110-847","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1310\/hpj5110-847","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1310\/hpj5110-847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:33:59Z","timestamp":1777451639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1310\/hpj5110-847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1310\/hpj5110-847"],"URL":"https:\/\/doi.org\/10.1310\/hpj5110-847","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,1]]}}}